Progrès en Urologie

2.4k papers and 10.5k indexed citations i.

About

The 2.4k papers published in Progrès en Urologie in the last decades have received a total of 10.5k indexed citations. Papers published in Progrès en Urologie usually cover Pulmonary and Respiratory Medicine (1.0k papers), Surgery (942 papers) and Rheumatology (832 papers) specifically the topics of Pelvic Floor Disorders (563 papers), Urinary Bladder and Prostate Research (547 papers) and Prostate Cancer Diagnosis and Treatment (480 papers). The most active scholars publishing in Progrès en Urologie are Morgan Rouprêt, Olivier Traxer, C. Saussine, É. Lechevallier, Jacques Irani, A. Ruffion, S. Droupy, Emmanuel Chartier‐Kastler, J. Rigaud and Thierry Lebrét.

In The Last Decade

Fields of papers published in Progrès en Urologie

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Progrès en Urologie. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Progrès en Urologie

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Progrès en Urologie. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Progrès en Urologie with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025